Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...
Robert F. Kennedy Jr., Trump's pick​ to lead the Department of Health and Human Services, has raised controversy on topics ...
Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...
The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.
Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...
Editorial writers dissect these public health topics.
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Welcome to the Biofrontera Inc. Third Quarter 2024 Financial ...
Donald Trump's pick for secretary of the Department of Health and Human Services is a fan of raw milk, despite the FDA saying ...
United Therapeutics is a leader in PAH treatments, with Tyvaso being the primary revenue driver. Check out why I rate UTHR ...